Literature DB >> 17000196

Fructose malabsorption and symptoms of irritable bowel syndrome: guidelines for effective dietary management.

Susan J Shepherd1, Peter R Gibson.   

Abstract

Dietary fructose induces abdominal symptoms in patients with fructose malabsorption, but there are no published guidelines on its dietary management. The objective was to retrospectively evaluate a potentially successful diet therapy in patients with irritable bowel syndrome and fructose malabsorption. Tables detailing the content of fructose and fructans in foods were constructed. A dietary strategy comprising avoidance of foods containing substantial free fructose and short-chain fructans, limitation of the total dietary fructose load, encouragement of foods in which glucose was balanced with fructose, and co-ingestion of free glucose to balance excess free fructose was devised. Sixty-two consecutively referred patients with irritable bowel syndrome and fructose malabsorption on breath hydrogen testing underwent dietary instruction. Dietary adherence and effect on abdominal symptoms were evaluated via telephone interview 2 to 40 months (median 14 months) later. Response to the diet was defined as improvement of all symptoms by at least 5 points on a -10- to 10-point scale. Forty-eight patients (77%) adhered to the diet always or frequently. Forty-six (74%) of all patients responded positively in all abdominal symptoms. Positive response overall was significantly better in those adherent than nonadherent (85% vs 36%; P<0.01), as was improvement in individual symptoms (P<0.01 for all symptoms). This comprehensive fructose malabsorption dietary therapy achieves a high level of sustained adherence and good symptomatic response.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17000196     DOI: 10.1016/j.jada.2006.07.010

Source DB:  PubMed          Journal:  J Am Diet Assoc        ISSN: 0002-8223


  84 in total

1.  Fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAPs) and nonallergic food intolerance: FODMAPs or food chemicals?

Authors:  Jacqueline S Barrett; Peter R Gibson
Journal:  Therap Adv Gastroenterol       Date:  2012-07       Impact factor: 4.409

2.  Event Surrogate from Clinical Pathway Completion to Daily Meal for Availability Extension Using Standard Electronic Medical Records: a Retrospective Cohort Study.

Authors:  Hiroki Furuhata; Kenji Araki; Taisuke Ogawa
Journal:  J Med Syst       Date:  2021-02-05       Impact factor: 4.460

Review 3.  Diagnosis and management of IBS.

Authors:  Sarah Khan; Lin Chang
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-10       Impact factor: 46.802

Review 4.  A Systematic Review of the Effects of Polyols on Gastrointestinal Health and Irritable Bowel Syndrome.

Authors:  Adrienne Lenhart; William D Chey
Journal:  Adv Nutr       Date:  2017-07-14       Impact factor: 8.701

5.  The Low FODMAP Diet for Treatment of Irritable Bowel Syndrome and Other Gastrointestinal Disorders.

Authors:  Jane G Muir; Peter R Gibson
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-07

6.  Immunopathogenesis of celiac disease.

Authors:  Jason Tye-Din; Robert Anderson
Journal:  Curr Gastroenterol Rep       Date:  2008-10

7.  Food for thought.

Authors:  Joseph H Sellin
Journal:  Curr Gastroenterol Rep       Date:  2009-10

8.  Fructose malabsorption is not uncommon among patients with irritable bowel syndrome in India: a case-control study.

Authors:  Atul Sharma; Deepakshi Srivastava; Abhai Verma; Asha Misra; Uday C Ghoshal
Journal:  Indian J Gastroenterol       Date:  2014-07-29

9.  Effects of a Low FODMAP Diet and Specific Carbohydrate Diet on Symptoms and Nutritional Adequacy of Patients with Irritable Bowel Syndrome: Preliminary Results of a Single-blinded Randomized Trial.

Authors:  Massimo Vincenzi; Irene Del Ciondolo; Elisa Pasquini; Katia Gennai; Barbara Paolini
Journal:  J Transl Int Med       Date:  2017-06-30

Review 10.  Intestinal microbiota and its role in irritable bowel syndrome (IBS).

Authors:  Lena Ohman; Magnus Simrén
Journal:  Curr Gastroenterol Rep       Date:  2013-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.